Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 71.2 USD 1.08%
Market Cap: 12.7B USD
Have any thoughts about
Insmed Inc?
Write Note

Intrinsic Value

INSM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one INSM stock under the Base Case scenario is 55.49 USD. Compared to the current market price of 71.2 USD, Insmed Inc is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INSM Intrinsic Value
55.49 USD
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Insmed Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for INSM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about INSM?
Bearish
Neutral
Bullish

Fundamental Analysis

71.2 USD
+1.08%
+1.08%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Insmed Inc
US
Biotechnology
Market Cap
12.7B USD
IPO
Feb 15, 1991
Employees
613
United States of America
Market Cap
12.7B USD
Industry
Biotechnology
IPO
Feb 15, 1991
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Insmed Inc

Provide an overview of the primary business activities
of Insmed Inc.

What unique competitive advantages
does Insmed Inc hold over its rivals?

What risks and challenges
does Insmed Inc face in the near future?

Has there been any significant insider trading activity
in Insmed Inc recently?

Summarize the latest earnings call
of Insmed Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Insmed Inc.

Provide P/S
for Insmed Inc.

Provide P/E
for Insmed Inc.

Provide P/OCF
for Insmed Inc.

Provide P/FCFE
for Insmed Inc.

Provide P/B
for Insmed Inc.

Provide EV/S
for Insmed Inc.

Provide EV/GP
for Insmed Inc.

Provide EV/EBITDA
for Insmed Inc.

Provide EV/EBIT
for Insmed Inc.

Provide EV/OCF
for Insmed Inc.

Provide EV/FCFF
for Insmed Inc.

Provide EV/IC
for Insmed Inc.

Show me price targets
for Insmed Inc made by professional analysts.

What are the Revenue projections
for Insmed Inc?

How accurate were the past Revenue estimates
for Insmed Inc?

What are the Net Income projections
for Insmed Inc?

How accurate were the past Net Income estimates
for Insmed Inc?

What are the EPS projections
for Insmed Inc?

How accurate were the past EPS estimates
for Insmed Inc?

What are the EBIT projections
for Insmed Inc?

How accurate were the past EBIT estimates
for Insmed Inc?

Compare the revenue forecasts
for Insmed Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Insmed Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Insmed Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Insmed Inc compared to its peers.

Compare the P/E ratios
of Insmed Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Insmed Inc with its peers.

Analyze the financial leverage
of Insmed Inc compared to its main competitors.

Show all profitability ratios
for Insmed Inc.

Provide ROE
for Insmed Inc.

Provide ROA
for Insmed Inc.

Provide ROIC
for Insmed Inc.

Provide ROCE
for Insmed Inc.

Provide Gross Margin
for Insmed Inc.

Provide Operating Margin
for Insmed Inc.

Provide Net Margin
for Insmed Inc.

Provide FCF Margin
for Insmed Inc.

Show all solvency ratios
for Insmed Inc.

Provide D/E Ratio
for Insmed Inc.

Provide D/A Ratio
for Insmed Inc.

Provide Interest Coverage Ratio
for Insmed Inc.

Provide Altman Z-Score Ratio
for Insmed Inc.

Provide Quick Ratio
for Insmed Inc.

Provide Current Ratio
for Insmed Inc.

Provide Cash Ratio
for Insmed Inc.

What is the historical Revenue growth
over the last 5 years for Insmed Inc?

What is the historical Net Income growth
over the last 5 years for Insmed Inc?

What is the current Free Cash Flow
of Insmed Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Insmed Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Insmed Inc

Current Assets 1.6B
Cash & Short-Term Investments 1.5B
Receivables 42.3m
Other Current Assets 139.6m
Non-Current Assets 403.1m
PP&E 110.2m
Intangibles 196m
Other Non-Current Assets 96.9m
Current Liabilities 259.2m
Accounts Payable 68.7m
Accrued Liabilities 187.6m
Other Current Liabilities 2.9m
Non-Current Liabilities 1.3B
Long-Term Debt 979.7m
Other Non-Current Liabilities 330.7m
Efficiency

Earnings Waterfall
Insmed Inc

Revenue
343m USD
Cost of Revenue
-78m USD
Gross Profit
264.9m USD
Operating Expenses
-968.9m USD
Operating Income
-703.9m USD
Other Expenses
-160.4m USD
Net Income
-864.3m USD

Free Cash Flow Analysis
Insmed Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

INSM Profitability Score
Profitability Due Diligence

Insmed Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
39/100
Profitability
Score

Insmed Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

INSM Solvency Score
Solvency Due Diligence

Insmed Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
40/100
Solvency
Score

Insmed Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 91.19 USD with a low forecast of 75.75 USD and a high forecast of 110.25 USD.

Lowest
Price Target
75.75 USD
6% Upside
Average
Price Target
91.19 USD
28% Upside
Highest
Price Target
110.25 USD
55% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for INSM?

Click here to dive deeper.

Dividends

Insmed Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for INSM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

INSM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

INSM News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one INSM stock?

The intrinsic value of one INSM stock under the Base Case scenario is 55.49 USD.

Is INSM stock undervalued or overvalued?

Compared to the current market price of 71.2 USD, Insmed Inc is Overvalued by 22%.

Back to Top